The Berlin facility is located within the
Max-Delbrück-Center biotech campus north of Berlin and covers
an area of approx. 1,600 square meters. The facility produces
clinical trial materials based on the fully-implemented MVA-BN®
The facility is under closure and all activities will be
transferred to the facility in Kvistgaard, Denmark during 2013.
View Bavarian Nordic in a larger map